Drug Shortage and Recall: Ranitidine 25 mg/mL X 2 mL injectable

The Issue: Ranitidine injectable is on backorder due to a Health Canada hold on distribution while further quality assurance testing is performed. This is related to the NDMA impurity found in oral ranitidine products earlier this year.

Anticipated Availability: Unknown resupply date at this time.

Further information and practice implications